Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$4,508,221
+$142,034 QoQ
Shares Held
17,751
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
#1,697
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Magnus Financial Group LLC holds $17,479,262 across 9 Drug Manufacturers - General names. JNJ ranks #2 (25.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,605 | $7,922,235 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
17,751 | $4,508,221 | |
| 3 | ABBV |
AbbVie Inc.
|
6,845 | $1,722,475 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,351 | $944,603 | |
| 5 | PFE |
Pfizer Inc
|
31,451 | $757,340 | |
| 6 | AMGN |
Amgen Inc
|
1,429 | $517,469 | |
| 7 | NVS |
Novartis AG
|
2,782 | $435,995 | |
| 8 | AZN |
Astrazeneca PLC
|
1,877 | $355,916 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,508,221 | 17,751 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $4,366,187 | 17,862 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $3,989,582 | 19,278 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $3,968,358 | 21,402 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $5,581,485 | 36,540 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $8,532,633 | 51,451 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $11,060,971 | 76,483 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $15,186,156 | 93,707 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $15,379,101 | 105,221 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,903,658 | 12,034 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,805,331 | 11,518 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,814,954 | 11,653 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,913,080 | 11,558 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $1,897,975 | 12,245 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,074,400 | 11,743 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,928,464 | 11,805 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,894,741 | 10,674 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,749,260 | 9,870 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,392,167 | 8,138 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,303,951 | 8,074 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,319,732 | 8,011 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,272,726 | 7,744 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,342,294 | 8,529 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,172,281 | 7,874 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,089,882 | 7,750 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,014,290 | 7,735 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||